Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma
Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma
Active, not recruiting · NCT01849263 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 2 | 2026-09-11 | NCT01849263 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fox Chase Cancer Center | Philadelphia | United States | 259 |
| Juravinski Cancer Centre at Hamilton Health Sciences | Hamilton | Canada | 60 |
| Kingston Health Sciences Centre | Kingston | Canada | 91 |
| Mayo Clinic in Arizona | Scottsdale | United States | 191 |
| Mayo Clinic in Florida | Jacksonville | United States | 224 |
| Mayo Clinic in Rochester | Rochester | United States | 687 |
| Metro Minnesota Community Oncology Research Consortium | Saint Louis Park | United States | 30 |
| National Cancer Centre Singapore | Singapore | Singapore | 61 |
| National University Hospital Singapore | Singapore | Singapore | 14 |
| Park Nicollet Clinic - Saint Louis Park | Saint Louis Park | United States | 252 |
| University Health Network-Princess Margaret Hospital | Toronto | Canada | 88 |
| University of Wisconsin Carbone Cancer Center - University Hospital | Madison | United States | 249 |
| Washington University School of Medicine | St Louis | United States | 895 |